Thrivent Financial for Lutherans
VXRT

Thrivent Financial for Lutherans’s Vaxart VXRT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-560,322
Closed -$3.39M – 2531
2021
Q1 		$3.39M Buy
560,322
+540,476
+2,723% +$4.16M 0.01% 1095
2020
Q4 		$113K Buy
+19,846
New +$126K ﹤0.01% 2439

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Thrivent Financial for Lutherans's VXRT Position: Q2 2021 in Review

Thrivent Financial for Lutherans sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 560,322 shares — an estimated $3.39M sold.

Thrivent Financial for Lutherans first reported a position in VXRT in Q4 2020 and held it in 2 quarters. The position peaked at $3.39M in Q1 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

  • Thrivent Financial for Lutherans reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 560,322 Vaxart shares in Q2 2021, an estimated $3.39M.
  • Thrivent Financial for Lutherans first reported a position in Vaxart in Q4 2020 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's Vaxart position peaked at $3.39M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.